stars 1 stars 2 stars 3

Bioalternatives is a private company (Contract Research Organization) specialized in cellular and molecular pharmacology. Bioalternatives provides services to support the early stages of drug discovery and the claim substantiation of healthcare compounds using up-to-date in vitro solutions. Bioalternatives develops and manages informative cell-based assays allowing faster and cost-effective selection of your compounds. Our capabilities include: - in vitro model development & characterization - development & management of cell-based assays - biological target identification - primary and secondary screening for hit to lead identification - profiling, mechanism of action studies; proof-of-concept evidencing - analysis of preclinical/clinical samples

BIOalternatives Questions

The BIOalternatives annual revenue was $3 million in 2026.

7 people are employed at BIOalternatives.

BIOalternatives is based in New York City, New York.

The NAICS codes for BIOalternatives are [5417, 541713, 541, 54, 54171].

The SIC codes for BIOalternatives are [873, 87].

Top BIOalternatives Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users